Condition: Diabetic Nephropathies · Primary Focal Segmental Glomerulosclerosis · Minimal Change Disease · Sponsor: Walden Biosciences
This is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with glomerular kidney disease and proteinuria, including diabetic nephropathy and rare glomerular kidney diseases (primary focal segmental glomerulosclerosis \[FSGS\], treatment-resistant minimal change disease \[TR MCD\], primary immunoglobulin A nephropathy \[IgAN\], and primary membranous nephropathy \[PMN\]). Subjects in this study will be randomized to receive the investigational drug WAL0921 or placebo as an intravenous infusion once every 2 weeks for 7 total infusions. All subjects will be followed for 24 weeks after their last infusion.
This description comes directly from the study's public registry record.
Michelle Skupien · 8573141961 · clinicaltrials@waldenbiosciences.com
Always discuss trial participation with your own doctor first.
| Academic Medical Research Institute | Los Angeles, California, United States | Recruiting |
| Colorado Kidney and Vascular Care | Denver, Colorado, United States | Recruiting |
| D & H Tamarac Research Center | Tamarac, Florida, United States | Recruiting |
| Fides Clinical Research | Atlanta, Georgia, United States | Recruiting |
| Nephrology Associates of Northern Illinois and Indiana (NANI) | Hinsdale, Illinois, United States | Recruiting |
| Dunes Clinical Research | Dakota Dunes, South Dakota, United States | Recruiting |
| Prolato Clinical Research Center | Houston, Texas, United States | Recruiting |
| Clinical Trial Network | Houston, Texas, United States | Recruiting |
| Clinical Advancement Center | San Antonio, Texas, United States | Recruiting |
| Westmead Hospital | Westmead, New South Wales, Australia | Recruiting |
| Western Health Sunshine Hospital | St Albans, Victoria, Australia | Recruiting |
| AIIMS Hospital | Raipur, Chhattisgarh, India | Recruiting |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06466135